exhibit

Madrigal Pharmaceuticals Inc

data

$CACO Perhaps the biggest kick in the nuts is seeing this garbage $MDGL hit all time highs yesterday at $315 after reporting NASH data.

$MDGL as good as the phase 3 data was this is fuckin nuts and the manipulation couldn&#39;t be more blatant.

Data is not even as good as some competitors

$MDGL So many irregularities with the data.

$MDGL if you look at the data closer, it is actually a disgused failure.

This market is a shit show that wants to collapse and any bad data this will get eviscerated!

The data is dropping with an 830am eastern time conference call.

Leaving data to last possible minute isn’t a good sign.

market

$MDGL this stock market is so full of shit.

$MDGL $VKTX markets going up and this aint.

Suddenly you realize the market is not as big as they are claiming!

$MDGL This is a perfect example of what is wrong with this market still.

show

$MDGL Today is going to be an absolute shit show likely with markets tanking and no news here.

strike

suck

$MDGL For all the mean and rude assholes out there.

WTF Jerry even the neighborhood asshole can be civil.

$MDGL down down down let’s go bears fuck this piece of crap

$MDGL a lot of options for tomorrow are being fucked with.

BUY AZYO here while you can at $4.30 on its way to $15!

$OTRK looks better buy today, looking 5 year chat.

This is no sympathy play ▶️ buy buy buy!

$MDGL Still lookin good 
 
$MRNA Still watching along with $TSLA here 
 
BUY AZYO WITH BOTH HANDS!!!

There are very attractive buys out there like Tesla at 120s.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

I don’t have to wait for fda approval for such low MC like ETNB is good promising data in next 3 weeks .. it can 3x my investments .. like AKRO is seating at 2B… ETNB HAS a strong potential for 2-3x from here next 3-4 weeks

This is an outstanding setup for $VKTX&#39;s VK2809 P2b study which is scheduled to release data in Q2 2023.

Well for genius shorts who can&#39;t read medical data, this is a GREAT shorting opportunity.

$VKTX from what I&#39;ve read from the preliminary trial data, the molecule is good, maybe better than $MDGL and has applications in weightloss.

$MDGL $ALT $TERN will wind up better with much better data.

With slam-dunk efficacy data and two years worth of safety data with no significant adverse safety events reported, Resmetirom has a clear path forward to accelerated approval.

$MDGL their PhIII data are so resoundingly positive that this has been termed a “watershed moment” and a “shock win” for the company.

bull

$MDGL cheers bulls great finish to the year!

$MDGL congrats to all longs and bulls here.

$MDGL benefits of owning low float market king bull.

$MDGL  
The MM now  
ok guys we did a great job this week let&#39;s celebrate Christmas and enjoy the fool&#39;s bulls&#39; money

$MDGL The horns on this bull are massive.

$MDGL - Congrats bulls on MDGL&#39;s stellar P3 performance and strong price run especially leading up to the holidays.

trial

$MDGL this is the cream of the crop, we already have stellar phase 3 results in the books.

$MDGL nice opportunity to add a few hundred shares here 😆  the celebration of shorts today reminded me when the stock price dropped sharply by 27% in a couple of days before trial readout.

Based on my multi year knowledge in NASH field, mdgl management so far did the best execution of clinical development - too many things to exemplify here!

Study results showed statistically significant absolute reductions in hepatic fat fraction at week 13 with pegozafermin administered every week or every two weeks compared to placebo.

After reaching its endpoints on its Phase 3 data we have seen a $240 spike!

Plus, remember this company is light years ahead of its competitors none of whom have had success with Phase 3. Bullish!

$VKTX Truth: VKTX increased more than 100% last 3 days since $MDGL has Phase 3 results.

Gladstone Commercial Corp

$GOOD https://www.stockilluminati.com/good/news.php - My Dividend Stock Portfolio: New February Record - 99 Holdings With 32 Buys And 4 Sales

$GOOD latest rating from EF Hutton and Company on 2023-02-24, setting target price at: USD 18.00 with a rating of Buy.

$GOOD https://www.stockilluminati.com/good/news.php - My Dividend Stock Portfolio: New November Record - 100 Holdings With 24 Buys, 1 Sale

$GOOD NEW ARTICLE : Colliers Securities Sticks to Their Buy Rating for Gladstone Commercial (GOOD) https://www.stck.pro/news/GOOD/37286749

$GOOD https://www.stockilluminati.com/good/news.php - My Dividend Stock Portfolio: New October Record - 103 Holdings With 27 Buys

$GOOD NEW ARTICLE : EF Hutton Sticks to Their Buy Rating for Gladstone Commercial (GOOD) https://www.stck.pro/news/GOOD/37269370

$GOOD Buy for the dividend and also enjoy some capital appreciation.

$GOOD just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/good/0001193125-23-074452.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

$GOOD just filed with the SEC a New Agreement and a Financial Exhibit https://last10k.com/sec-filings/good/0001193125-23-005580.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

$GOOD just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/good/0001193125-22-302740.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

$GOOD just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/good/0001234006-22-000016.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=8K&amp;utm_term=good

rating

announces

Gladstone Commercial Corporation Announces Common Stock Repurchase Authorization MCLEAN, Va.,  https://www.conferencecalltranscripts.org/summary/?id=11925505 $GOOD

$GOOD 📰 Gladstone Commercial Corporation Announces Common Stock Repurchase Authorization

https://quantisnow.com/i/4222623?utm_source=stocktwits

45 seconds delayed.

Gladstone Commercial Corporation Announces Share Repurchase Authorization MCLEAN, Va.,  https://www.conferencecalltranscripts.org/summary/?id=11606287 $GOOD

$GOOD 📰 Gladstone Commercial Corporation Announces Share Repurchase Authorization

https://quantisnow.com/i/3793044?utm_source=stocktwits

45 seconds delayed.

company

$GOOD GOOD / Gladstone Commercial Corporation Price Target Updated 
https://fintel.io/sfo/us/good

$GOOD 📜 SEC Form S-3ASR filed by Gladstone Commercial Corporation Real Estate Investment Trust

https://quantisnow.com/i/3728004?utm_source=stocktwits

45 seconds delayed.

Gladstone Commercial Corporation director just declared owning 350 shares of Gladstone Commerci https://www.conferencecalltranscripts.org/summary/?id=11401896 $GOOD

Boston Properties, Inc.

Buy slowly and patiently in good companies. Cheers!

We alerted the BUY signal at $52.1 and we were able to close this one with profit at $54.85 🔏

We alerted the BUY signal at $66.21 and we were able to close this one with profit at $66.18 ✅

Jim Cramer Says This Stock Up 23% In A Month Is &#39;A Great Speculative Buy&#39;  
https://www.benzinga.com/trading-ideas/long-ideas/23/01/30455566/jim-cramer-says-this-stock-up-23-in-a-month-is-a-great-speculative-buy 
$BA $BHVN $BXP $GSK $PFE

Buy value and safe long and short term opportunities!

$BXP - Boston Properties: My Oh My, A Blue-Chip Strong Buy.

$BXP https://www.stockilluminati.com/bxp/news.php - Boston Properties: My Oh My, A Blue-Chip Strong Buy

$BXP NEW ARTICLE : Boston Properties: My Oh My, A Blue-Chip Strong Buy https://www.stck.pro/news/BXP/35218825

Owned by BXP (NYSE: BXP), the world-class observatory, designed with the adventurer in mind, features state-of-the-art immersive experiential exhibits, 360° breathtaking views of the city, and more.

BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023 https://conferencecalltranscripts.com/summary/?id=483590&amp;pr=true $BXP

BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023 https://conferencecalltranscripts.com/summary/?id=483589&amp;pr=true $BXP

$BXP https://www.stockilluminati.com/bxp/news.php - BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023

$BXP BXP Maintains Industry Leadership, Improves Ranking in Newsweek’s List of the Most Responsible Companies For 2023
https://www.stocktitan.net/news/BXP/bxp-maintains-industry-leadership-improves-ranking-in-newsweek-s-ae2ju206lug6.html

BXP ranked first in the Real Estate &amp; Housing industry with an increased ranking of 29th overall out of the 500 companies included and had the third highest environmental score.

industry

price

$BXP  
 
 Signal Update  
 
 As of today, BXP is up +3.77 percent from buy price 72.29 in 8days and on track to achieve target price 75.71.

$BXP  
 
 Signal Update  
 
 As of today, BXP is up +2.55 percent from buy price 72.29 in 8days and on track to achieve target price 75.71.

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Jan, 27, 2023

Jan, 24, 2023

GOOD

Gladstone Commercial Corp

-28.20%

$16.70 - $11.99

Mar, 20, 2023

Mar, 7, 2023

Discover Your Wealth Potential with Stock Advisor

BXP

Boston Properties, Inc.

-31.61%

$73.04 - $49.95

Mar, 20, 2023

Mar, 16, 2023

MDGL

Madrigal Pharmaceuticals Inc

-10.68%

$275.00 - $245.64

Jan, 27, 2023

Jan, 24, 2023

Jan, 18, 2023

Dec, 30, 2022

Dec, 28, 2022

Dec, 22, 2022

Dec, 21, 2022

Dec, 21, 2022

Dec, 20, 2022

Dec, 19, 2022

GOOD

Gladstone Commercial Corp

-28.20%

$16.70 - $11.99

BXP

Boston Properties, Inc.

-31.61%

$73.04 - $49.95